You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

MEFLOQUINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Mefloquine Hydrochloride, and when can generic versions of Mefloquine Hydrochloride launch?

Mefloquine Hydrochloride is a drug marketed by Barr, Hikma, Hikma Intl Pharms, Sandoz, and Us Army Walter Reed. and is included in five NDAs.

The generic ingredient in MEFLOQUINE HYDROCHLORIDE is mefloquine hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the mefloquine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Mefloquine Hydrochloride

A generic version of MEFLOQUINE HYDROCHLORIDE was approved as mefloquine hydrochloride by BARR on December 29th, 2003.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MEFLOQUINE HYDROCHLORIDE?
  • What are the global sales for MEFLOQUINE HYDROCHLORIDE?
  • What is Average Wholesale Price for MEFLOQUINE HYDROCHLORIDE?
Drug patent expirations by year for MEFLOQUINE HYDROCHLORIDE
Recent Clinical Trials for MEFLOQUINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Prodia Diacro Laboratories P.T.N/A
National Research and Innovation Agency of IndonesiaN/A
Universitas PadjadjaranN/A

See all MEFLOQUINE HYDROCHLORIDE clinical trials

Pharmacology for MEFLOQUINE HYDROCHLORIDE
Drug ClassAntimalarial
Medical Subject Heading (MeSH) Categories for MEFLOQUINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for MEFLOQUINE HYDROCHLORIDE

US Patents and Regulatory Information for MEFLOQUINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr MEFLOQUINE HYDROCHLORIDE mefloquine hydrochloride TABLET;ORAL 076392-001 Dec 29, 2003 AB RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz MEFLOQUINE HYDROCHLORIDE mefloquine hydrochloride TABLET;ORAL 076175-001 Feb 20, 2002 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma MEFLOQUINE HYDROCHLORIDE mefloquine hydrochloride TABLET;ORAL 076523-001 Oct 1, 2004 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma Intl Pharms MEFLOQUINE HYDROCHLORIDE mefloquine hydrochloride TABLET;ORAL 077699-001 Apr 21, 2010 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Us Army Walter Reed MEFLOQUINE HYDROCHLORIDE mefloquine hydrochloride TABLET;ORAL 019578-001 May 2, 1989 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.